1. Home
  2. AURA vs CCSI Comparison

AURA vs CCSI Comparison

Compare AURA & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • CCSI
  • Stock Information
  • Founded
  • AURA 2007
  • CCSI 2021
  • Country
  • AURA United States
  • CCSI United States
  • Employees
  • AURA N/A
  • CCSI N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • CCSI Retail: Computer Software & Peripheral Equipment
  • Sector
  • AURA Health Care
  • CCSI Technology
  • Exchange
  • AURA Nasdaq
  • CCSI Nasdaq
  • Market Cap
  • AURA 396.8M
  • CCSI 450.6M
  • IPO Year
  • AURA 2021
  • CCSI N/A
  • Fundamental
  • Price
  • AURA $6.56
  • CCSI $19.83
  • Analyst Decision
  • AURA Strong Buy
  • CCSI Hold
  • Analyst Count
  • AURA 6
  • CCSI 5
  • Target Price
  • AURA $22.33
  • CCSI $27.20
  • AVG Volume (30 Days)
  • AURA 217.2K
  • CCSI 145.4K
  • Earning Date
  • AURA 08-07-2025
  • CCSI 08-07-2025
  • Dividend Yield
  • AURA N/A
  • CCSI N/A
  • EPS Growth
  • AURA N/A
  • CCSI N/A
  • EPS
  • AURA N/A
  • CCSI 4.32
  • Revenue
  • AURA N/A
  • CCSI $349,374,000.00
  • Revenue This Year
  • AURA N/A
  • CCSI $1.18
  • Revenue Next Year
  • AURA N/A
  • CCSI $0.56
  • P/E Ratio
  • AURA N/A
  • CCSI $4.74
  • Revenue Growth
  • AURA N/A
  • CCSI N/A
  • 52 Week Low
  • AURA $4.35
  • CCSI $16.68
  • 52 Week High
  • AURA $12.38
  • CCSI $32.10
  • Technical
  • Relative Strength Index (RSI)
  • AURA 53.66
  • CCSI 30.23
  • Support Level
  • AURA $6.37
  • CCSI $21.18
  • Resistance Level
  • AURA $6.79
  • CCSI $24.36
  • Average True Range (ATR)
  • AURA 0.37
  • CCSI 0.82
  • MACD
  • AURA 0.01
  • CCSI -0.35
  • Stochastic Oscillator
  • AURA 60.72
  • CCSI 0.66

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

Share on Social Networks: